NPPA fixed retail price of 42 formulations: February 2025

Last Updated on February 13, 2025 by The Health Master

NPPA

Download NPPA notification No. S.O. 660 (E) dt 07-02-2025, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 42 formulations under the Drugs (Prices Control) Order, 2013, vide S.O. 660(E) dt 07-02-2025 based on the decision of 129th Authority meeting dated 29-01-2025.

The notification states as follows:

In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

A table is given below the article

Note:

(a) The manufacturer of the above-mentioned formulations, i.e., the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have actually paid it or it is payable to the Government on the retail price mentioned in column (6) of the above-mentioned table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013.

The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above, i.e., those who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to the fulfillment of all the applicable statutory requirements as laid down by the government under relevant statutes or rules, including manufacturing license permission from the competent authority, i.e., the central or state licensing authority, as may be applicable, by the concerned manufacturer/marketing company.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per the instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of the manufacturer and marketing company specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer and marketing company Companies as specified in corresponding entries in Columns (2), (3), and (5) thereof, if any, issued prior to this notification, stand superseded.

Table

S. No.	Medicines	Strength	Unit	Manufacturer & Marketing Company	Retail Price (in Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Tranexamic Acid	Each film coated tablet contains:	1 Tablet	M/s Skymap	32.57
	and Mefenamic Acid	Tranexamic Acid IP 500 mg		Pharmaceuticals
	tablets	Mefenamic Acid IP 250 mg		Pvt. Ltd./ M/s
				Glensmith Labs
				Pvt. Ltd.
2	Sitagliptin &	Each film coated bilayered tablet	1 Tablet	M/s Pure and Cure	12.84
	Metformin	contains:		Healthcare Pvt.
	Hydrochloride	Sitagliptin Phosphate Monohydrate		Ltd./
	(Sustained Release) Tablets	IP eq. to Sitagliptin 100 mg Metformin Hydrochloride IP 500 mg (as Sustained Release)		M/s Primus Remedies Pvt. Ltd.
3	Dapagliflozin, Glimepiride, Metformin Hydrochloride (extended release) tablets	Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg, Glimepiride IP 1 mg, Metformin Hydrochloride IP 500 mg (As Extended Release)	1 Tablet	M/s Mascot Health Series Pvt. Ltd./ M/s La Renon Healthcare Pvt. Ltd.	12.31
4	Dapagliflozin, Glimepiride, Metformin Hydrochloride (Extended Release) tablets	Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg, Glimepiride IP 2 mg, Metformin Hydrochloride IP 500 mg (as Extended Release)	1 Tablet	M/s Mascot Health Series Pvt. Ltd./ M/s La Renon Healthcare Pvt. Ltd.	12.62
5	Glimepiride, Voglibose & Metformin Hydrochloride (SR) tablets	Each uncoated bilayered tablet contains: Glimepiride IP 0.5 mg, Voglibose IP 0.2 mg, Metformin Hydrochloride IP 500 mg (as Sustained Release form)	1 Tablet	M/s Windlas Biotech Limited/ M/s Mankind Pharma Ltd.	9.12
6	Bictegravir, Emtricitabine & Tenofovir Alafenamide Tablets	Each film coated tablet contains: Bictegravir Sodium eq. to Bictegravir 50 mg, Emtricitabine IP 200 mg Tenofovir Alafenamide Fumarate IP eq. to Tenofovir Alafenamide 25 mg	1 Tablet	M/s Hetero Labs Limited / M/s Cipla Ltd.	132.58
7	Glimepiride & Metformin Hydrochloride (SR) tablets	Each uncoated bilayered tablet contains: Glimepiride IP 1 mg Metformin Hydrochloride IP 1000 mg (as Sustained Release form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd.	9.40
8	Glimepiride & Metformin Hydrochloride (SR) tablets	Each uncoated bilayered tablets contains: Glimepiride IP 3 mg, Metformin HCl IP 1000mg (Sustained Release form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd.	12.03
9	Glimepiride & Metformin Hydrochloride (SR) tablets	Each uncoated bilayered tablets contains: Glimepiride IP 4 mg, Metformin HCl IP 1000mg (as Sustained Release form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd.	12.39
10	Empagliflozin & Metformin Hydrochloride tablets	Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Micro Labs Ltd.	15.84

11	Empagliflozin & Metformin Hydrochloride tablets	Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Micro Labs Ltd.	18.10
12	Empagliflozin & Metformin Hydrochloride tablets	Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg	1 Tablet	M/s Micro Labs Ltd.	19.01
13	Empagliflozin & Metformin Hydrochloride tablets	Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg	1 Tablet	M/s Micro Labs Ltd.	11.38
14	Linezolid for Oral Suspension	Each 5 ml of constituted suspension contains: Linezolid IP 100 mg	1 ml	M/s Pure & Cure Healthcare Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd.	3.86
15	Telmisartan, Cilnidipine & Chlorthalidone tablets	Each film coated tablet contains: Telmisartan IP 40 mg, Cilnidipine IP 10 mg, Chlorthalidone IP 12.50 mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Corona Remedies Pvt. Ltd.	15.07
16	Telmisartan, Cilnidipine & Chlorthalidone tablets	Each film coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Chlorthalidone IP 6.25 mg	1 Tablet	M/s Synokem Pharmaceuticals Ltd. /M/s Cadila Pharmaceuticals Ltd.	14.69
17	Telmisartan & Hydrochlorothiazide tablets	Each uncoated bilayered tablet contains: Telmisartan IP 40mg, Hydrochlorothiazide IP 12.5 mg	1 Tablet	M/s Sano-Cito Therapeutics Inc- Unit-II / M/s Zuventus Healthcare Ltd.	11.43
18	Atorvastatin & Ezetimibe tablets	Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 80 mg, Ezetimibe IP 10 mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Cadila Pharmaceuticals Ltd.	53.70
19	Atorvastatin & Ezetimibe tablets	Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 80 mg, Ezetimibe IP 10 mg	1 Tablet	M/s Windlas Biotech Ltd. / M/s Cadila Pharmaceuticals Ltd.	53.70
20	Diclofenac Sodium, Paracetamol & Chlorzoxazone tablets	Each uncoated tablet contains: Diclofenac Sodium IP 50mg, Paracetamol IP 325mg Chlorzoxazone USP 250mg	1 Tablet	M/s Aagya Biotech Pvt. Ltd./ M/s Macleods Pharmaceuticals Ltd.	6.55

21	Levetiracetam tablets	Each film coated tablet contains: Levetiracetam IP 1000 mg	1 Tablet	M/s Macleods Pharmaceuticals Ltd.	35.94
22	Clindamycin & Nicotinamide gel	Composition: Clindamycin Phosphate IP eq. to Clindamycin 1.0% w/w Nicotinamide IP 4.0% w/w	1 Gm	M/s Pilco Healthcare Pvt. Ltd. /M/s Glensmith Labs Pvt. Ltd	7.35
23	Cefadroxil & Potassium Clavulanate dispersible tablets	Each uncoated dispersible tablet contains: Cefadroxil Monohydrate IP eq. to Anhydrous Cefadroxil 250 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 62.5 mg	1 Tablet	M/s Innova Captab Limited / M/s Indoco Remedies Ltd.	9.72
24	Cefadroxil & Potassium Clavulanate tablets	Each film coated tablet contains: Cefadroxil Monohydrate IP eq. to Anhydrous Cefadroxil 500 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg	1 Tablet	M/s Innova Captab Limited / M/s Indoco Remedies Ltd.	17.61
25	Bilastine & Montelukast Suspension	Each 5 ml suspension contains: Bilastine IP 10 mg Montelukast Sodium IP eq. To Montelukast 4mg	1 ml	M/s Synokem Pharmaceuticals Limited / M/s Intas Pharmaceuticals Limited	1.69
26	Amoxycillin & Potassium Clavulanate Oral Suspension	Each 5 ml of reconstituted suspension contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 600 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 42.9 mg	1 ml	M/s Malik Lifesciences Pvt. Ltd./ M/s Aurobindo Pharma Ltd.	2.68
27	Aspirin gastro- resistant & Atorvastatin capsules	Each hard gelatin capsule Contain: Aspirin IP 75 mg (as gastro- resistant tablet IP) Atorvastatin Calcium IP eq. to Atorvastatin 40 mg	1 Capsule	M/s Windlas Biotech Ltd. / M/s Intas Pharmaceuticals Ltd.	18.27
28	Bisoprolol Fumarate and Amlodipine Besilate tablets	Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg Amlodipine besilate IP eq. to Amlodipine 5 mg	1 Tablet	M/s Macleods Pharmaceuticals Ltd.	6.26
29	Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Tablets	Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 10mg Chlorpheniramine Maleate IP 2 mg	1 Tablet	M/s East African (India) Overseas /M/s Medley Pharmaceuticals Ltd.	4.81
30	Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine HCl tablets	Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 5 mg Diphenhydramine HCl IP 25 mg Caffeine IP (anhydrous) 30 mg	1 Tablet	M/s Juggat Pharma (Pharma Division of Jagdale Industries Pvt. Ltd.)	4.22

31	Paracetamol & Mefenamic Acid Suspension	Each 5 ml contains: Paracetamol IP 250 mg Mefenamic Acid IP 100 mg	1 ml	M/s Yacca Lifesciences Pvt. Ltd./ M/s Intas Pharmaceuticals Ltd.	0.88
32	Mefenamic Acid & Paracetamol Suspension	Each 5 ml contains: Mefenamic Acid IP 100 mg Paracetamol IP 250 mg	1 ml	M/s Shiva Biogenetic Pharmaceuticals Pvt. Ltd. /M/s Aristo Laboratories Pvt. Ltd.	0.88
33	Mefenamic Acid & Paracetamol Suspension	Each 5 ml contains: Mefenamic Acid IP 50 mg Paracetamol IP 125 mg	1 ml	M/s Shiva Biogenetic Pharmaceuticals Pvt. Ltd. /M/s Aristo Laboratories Pvt. Ltd.	0.73
34	Paracetamol & Polmacoxib tablets	Each uncoated tablet contains: Paracetamol IP 325 mg Polmacoxib IH 2 mg	1 Tablet	M/s Hetero Labs Ltd./ M/s Micro Labs Ltd.	15.26
35	Paracetamol & Polmacoxib tablets	Each uncoated tablet contains: Paracetamol IP 325 mg Polmacoxib IH 2 mg	1 Tablet	M/s Hetero Labs Ltd./ M/s Abbott Healthcare Pvt. Ltd.	15.26
36	Paracetamol & Polmacoxib tablets	Each uncoated tablet contains: Paracetamol IP 325 mg Polmacoxib IH 2 mg	1 Tablet	M/s Hetero Labs Limited/ M/s Mankind Pharma Ltd.	15.26
37	Polmacoxib and Paracetamol tablets	Each uncoated tablet contains: Paracetamol IP 325 mg Polmacoxib IH 2 mg	1 Tablet	M/s Hetero Labs Limited / M/s Torrent Pharmaceuticals Ltd.	15.26
38	Bisoprolol Fumarate and Amlodipine besilate tables	Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg Amlodipine besilate IP eq. to Amlodipine 5 mg	1 Tablet	M/s Macleods Pharmaceuticals Ltd.	8.54
39	Cetirizine Drops	Each ml contains: Cetirizine Hydrochloride IP 10 mg	1 ml	M/s Zuventus Healthcare Ltd.	7.78
40	Telmisartan, Cilnidipine & Chlorthalidone tablets	Each film coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Chlorthalidone IP 6.25 mg	1 Tablet	M/s Skymap Pharmaceuticals Pvt. Ltd. /M/s German Remedies Pharmaceuticals Pvt. Ltd.	14.92
41	Atorvastatin, Clopidogrel & Aspirin Capsules	Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 10 mg (As Pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (As Pellets) Aspirin IP 75 mg (as enteric coated Pellets)	1 Capsule	M/s Synokem Pharmaceuticals Ltd. / M/s Ipca Laboratories Ltd.	5.75
42	Atorvastatin, Clopidogrel & Aspirin Capsules	Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 20 mg (As Pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (As Pellets) Aspirin IP 75 mg (as enteric coated Pellets)	1 Capsule	M/s Synokem Pharmaceuticals Ltd. / M/s Ipca Laboratories Ltd.	7.95

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos by The Health Master, click on the below YouTube icon:

• NPPA revised ceiling price of 2 formulations: February 2025
  February 12, 2025
• Extension of the deadline for Revised Schedule M: Final notification
  February 12, 2025
• NPPA fixed retail price of 42 formulations: February 2025
  February 11, 2025
• Drug prices display is mandatory for all pharmacies: NPPA
  February 11, 2025
• New export norms for Erythromycin Stearate Tablets: DGFT
  February 10, 2025
• CDSCO Approval: For Vedolizumab Biosimilar Clinical Trial
  February 10, 2025

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: